… matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis -
T Luttenberger, A Schmid-Kotsas, A Menke, M Siech, … - Lab Invest, 2000 - nature.com
... BrdU) incorporation by 6.4 0.78 times and 10 0.29 times, respectively). ... We suggest
that platelets and PSC cooperate in the development of pancreas fibrosis. ...
Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications … -
CS Dayton, DA Schwartz, RA Helmers, RJ Pueringer, … - Chest, 1993 - Am Coll Chest Phys
... found online on the World Wide Web at: The ... monary fibrosis (IPF)whose conditions
clinically deteriorate while ... in those who have continued to survive (p =0.29). ...
… Growth Factor-{beta} Gene Polymorphisms in Sarcoidosis Patients With and Without Fibrosis -
A Kruit, JC Grutters, HJT Ruven, CHM van Moorsel, … - Chest, 2006 - Am Coll Chest Phys
... 6/1584 located on the World Wide Web at: The ... be significantly more abundant in
sarcoidosis patients with fibrosis (carrier frequency, 0.29) compared to ...
Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis -
J Bradley, O McAlister, S Elborn - European Respiratory Journal, 2001 - Eur Respiratory Soc
... The primary outcome measures used in cystic fibrosis (CF) are reflective of disease ...
a poor correlation between change in FEV 1 and change in CRP ( =0.29, p=0.25 ...
International Comparison of Median Age at Death From Cystic Fibrosis* -
A Fogarty, R Hubbard, J Britton - Chest, 2000 - Am Coll Chest Phys
... Search for citing articles in: ISI Web of Science (12). ... rankings, the OR of death
from cystic fibrosis above the ... being Scotland (OR, 0.42; 95% CI, 0.29 to 0.61 ...
Factors Influencing Outcomes in Cystic Fibrosis* A Center-Based Analysis -
C Johnson, SM Butler, MW Konstan, W Morgan, MEB … - Chest, 2003 - Am Coll Chest Phys
... Search for citing articles in: ISI Web of Science (2 ... of those accredited by the US
Cystic Fibrosis Foundation ... to 17 years (p = 0.007; 80 patients), 0.29 for ages ...
The Increase in Serum Soluble ST2 Protein Upon Acute Exacerbation of Idiopathic Pulmonary Fibrosis -
S Tajima, K Oshikawa, S Tominaga, Y Sugiyama - Chest, 2003 - Am Coll Chest Phys
... IL-1?, in the lower respiratory tract and the development of pulmonary fibrosis. ...
p < 0.05; before acute exacerbation vs on acute exacerbation, 0.29 ? 0.09 ng ...
… of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national … -
JS Ganesh, CA Rogers, RS Bonser, NR Banner - European Respiratory Journal, 2005 - Eur Respiratory Soc
... 1? -transplant characteristics of patients with cystic fibrosis (CF) and organ donors. ...
further (hazard ratio (BSLT versus HLT) = 0.77; 95% CI 0.29?2.06; p ...
Serum surfactant proteins-A and-D as biomarkers in idiopathic pulmonary fibrosis -
KE Greene, TE King, Y Kuroki, B Bucher-Bartelson, … - European Respiratory Journal, 2002 - Eur Respiratory Soc
... with normal films (64.8 ng?mL ?1 versus 34.0 ng?mL ?1 ; p=0.29). ... proteins-A and
-D levels and survival time in idiopathic pulmonary fibrosis The authors ...
Reduced bone density in cystic fibrosis:{Delta} F508 mutation is an independent risk factor -
SJ King, DJ Topliss, T Kotsimbos, IB Nyulasi, M … - European Respiratory Journal, 2005 - Eur Respiratory Soc
... Z-scores at the lumbar spine ( ) and femoral neck ( ) in adult cystic fibrosis
(CF) patients ... p = 0.94) or the FN (?0.23?1.24 and ?0.29?0.89, respectively ...
Source: Google Scholar |